Global Multiple Myeloma Drugs Market 2017-2021

2016-12-27
Price :
Published : Dec-2016
No. of Pages : 86

Multiple myeloma is an abnormal growth and accumulation of plasma cells in the bone marrow leading to malignancy. This can be caused by the overproduction of monoclonal immunoglobulins such as IgG, IgA, IgD, or IgE; or Bence-Jones protein. Under normal conditions, stem cells develop into B lymphocytes, mature in the lymph nodes, and are transported throughout the body. On the entry of foreign substances into the body, these B-cells develop into plasma cells and produce immunoglobulins against the disease. However, in multiple myeloma, the B-cells are damaged and give rise to many malignant plasma cells that produce excessive immunoglobulins of a single type, which the body does not require.

The analysts forecast the global multiple myeloma drugs market to grow at a CAGR of 9.19% during the period 2017-2021.

Covered in this report

This report covers the present scenario and the growth prospects of the global multiple myeloma drugs market for 2017-2021. To calculate the market size, This report considers the revenue generated from the sales of branded and generic drugs used to treat and prevent multiple myeloma.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

The report, Global Multiple Myeloma Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Amgen
  • Celgene
  • Johnson & Johnson
  • Novartis
  • Takeda Pharmaceuticals

Other prominent vendors

  • AB Science
  • AbbVie
  • Acceleron Pharma
  • Acetylon Pharmaceuticals
  • Adaptimmune Therapeutics
  • Alexion Pharmaceuticals
  • AmpliMed Corporation
  • Array BioPharma
  • Benovus Bio
  • BioInvent
  • Biokine Therapeutics
  • Biotest
  • bluebird bio
  • Bristol-Meyer Squibb
  • Calithera Biosciences
  • CASI Pharmaceuticals
  • Celldex Therapeutics
  • Cellectar Biosciences
  • Chroma Therapeutics
  • Cleave Biosciences
  • Curis
  • Dicerna Pharmaceuticals
  • Eureka Therapeutics
  • F. Hoffmann-La Roche
  • Geron Corporation
  • GlycoMimetics
  • GlaxoSmithKline
  • ImmunoGen
  • Immunomedics
  • Innate Pharma
  • JW Pharmaceutical
  • Karyopharm Therapeutics
  • Kyowa Hakko Kirin
  • Merck
  • Midatech Pharma
  • Mirna Therapeutics
  • Molecular Partners
  • MorphoSys
  • NOXXON Pharma
  • Oncoceutics
  • Oncolytics Biotech
  • OncoPep
  • Oncopeptides
  • Ono Pharmaceutical
  • Otsuka Pharmaceuticals
  • Patrys
  • PharmaMar
  • Polyphor
  • Prothena Therapeutics
  • Sanofi
  • Sevion Therapeutics
  • Specialised Therapeutics
  • Spectrum Pharmaceutical
  • SymBio Pharmaceuticals
  • TaiGen Biotechnology
  • Tragara Pharmaceuticals
  • Vaxil Therapeutics
  • Vivolux

Market driver

  • Growing demand for biologic therapies
  • For a full, detailed list, view our report

Market challenge

  • Growing popularity of complementary and alternative medicines (CAM)
  • For a full, detailed list, view our report

Market trend

  • Emergence of nanomedicine platform
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : Technavio
More Reports
Title Price Buy Now

Parkinson’s Disease: Epidemiology Forecast to 2026

Parkinson's Disease: Epidemiology Forecast to 2026 Summary Parkinson's disease (PD) is the second most common chronic progressive neurodegenerative disorder in the elderly, affecting 1-2% of individuals ages 65 years and older worldwide. PD is associated with motor symptoms involving bradykinesia, rest tremor, rigidity, and postural disturbances, as well as non-motor symptoms including hyposmia, rapid eye movements, sleep behavior disorder, and depression. Age, genetics, sex, and environmental exposure to pesticides increase the risk of developing PD. Conditions such as depression and anxiety have been identified as comorbidities in PD. For this analysis, GlobalData epidemiologists utilized peer-reviewed studies to construct the 10-year epidemiological forecast for the diagnosed prevale......
$3995

Paralysis Global Clinical Trials Review, H1, 2018

Paralysis Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Paralysis Global Clinical Trials Review, H1, 2018" provides an overview of Paralysis clinical trials scenario. This report provides top line data relating to the clinical trials on Paralysis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are coll......
$2500

Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H1, 2018

Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H1, 2018" provides an overview of Pelvic Inflammatory Disease (Pelvic Infections) clinical trials scenario. This report provides top line data relating to the clinical trials on Pelvic Inflammatory Disease (Pelvic Infections). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Gl......
$2500

Otitis Media Global Clinical Trials Review, H1, 2018

Otitis Media Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Otitis Media Global Clinical Trials Review, H1, 2018" provides an overview of Otitis Media clinical trials scenario. This report provides top line data relating to the clinical trials on Otitis Media. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical tri......
$2500

Paraplegia Global Clinical Trials Review, H1, 2018

Paraplegia Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Paraplegia Global Clinical Trials Review, H1, 2018" provides an overview of Paraplegia clinical trials scenario. This report provides top line data relating to the clinical trials on Paraplegia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are ......
$2500

Pemphigus Global Clinical Trials Review, H1, 2018

Pemphigus Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Pemphigus Global Clinical Trials Review, H1, 2018" provides an overview of Pemphigus clinical trials scenario. This report provides top line data relating to the clinical trials on Pemphigus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are coll......
$2500

Ovarian Cancer Global Clinical Trials Review, H1, 2018

Ovarian Cancer Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Ovarian Cancer Global Clinical Trials Review, H1, 2018" provides an overview of Ovarian Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Ovarian Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clin......
$2500

Parasitic Diseases Global Clinical Trials Review, H1, 2018

Parasitic Diseases Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Parasitic Diseases Global Clinical Trials Review, H1, 2018" provides an overview of Parasitic Diseases clinical trials scenario. This report provides top line data relating to the clinical trials on Parasitic Diseases. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trial......
$2500

Pemphigus Vulgaris Global Clinical Trials Review, H1, 2018

Pemphigus Vulgaris Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Pemphigus Vulgaris Global Clinical Trials Review, H1, 2018" provides an overview of Pemphigus Vulgaris clinical trials scenario. This report provides top line data relating to the clinical trials on Pemphigus Vulgaris. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trial......
$2500

Ovarian Disease Global Clinical Trials Review, H1, 2018

Ovarian Disease Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Ovarian Disease Global Clinical Trials Review, H1, 2018" provides an overview of Ovarian Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Ovarian Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. ......
$2500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy